p53 mutant mediates CXCR7 expression and function in breast cancer progression
碩士 === 中國醫藥大學 === 基礎醫學研究所碩士班 === 99 === CXCR7 was identified as a novel, alternate receptor for CXCL12 that promotes tumor growth and metastasis in breast cancer and other malignancies. However, the expression and function of CXCR7 in tumor progression is controversial. This issue may be due to comp...
Main Authors: | Shyuan-Ling Lin, 林瑄翎 |
---|---|
Other Authors: | 謝佳宏 |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/43999812932189422991 |
Similar Items
-
Expression of galectin-7 is induced in breast cancer cells by mutant p53.
by: Carole G Campion, et al.
Published: (2013-01-01) -
Mutant p53 in Cancer Progression and Targeted Therapies
by: Gaoyang Zhu, et al.
Published: (2020-11-01) -
Regulation of Mutant p53 protein expression
by: Reshma eVijayakumaran, et al.
Published: (2015-12-01) -
The role of CXCR4, CXCR7 and CCR7 in breast cancer metastatis
by: Del Molino del Barrio, Irene
Published: (2017) -
Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
by: Eduardo Alvarado-Ortiz, et al.
Published: (2021-02-01)